Literature DB >> 26405538

Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.

Chikara Ueyama1, Hideki Horibe1, Yuichiro Yamase1, Tetsuo Fujimaki2, Mitsutoshi Oguri3, Kimihiko Kato4, Masazumi Arai5, Sachiro Watanabe5, Toyoaki Murohara6, Yoshiji Yamada7.   

Abstract

Although genome-wide association studies (GWASs) have identified various genes and loci in predisposition to metabolic syndrome (MetS) or each component of this condition, the genetic basis of MetS in individuals remains to be identified definitively. The aim of the present study was to examine the possible association of MetS in individuals with 29 polymorphisms that were previously identified as susceptibility loci for coronary artery disease or myocardial infarction by meta-analyses of GWASs. The study population comprised 1,822 subjects with MetS and 1,096 controls. Subjects with MetS had ≥3 of the 5 components of the diagnostic criteria for MetS, whereas control individuals had 0-1 of the 5 components. The genotypes for the 29 polymorphisms were determined by the multiplex bead-based Luminex assay. Comparisons of allele frequencies by the χ2 test revealed that rs17514846 (A→C) of the furin (paired basic amino acid-cleaving enzyme) gene (FURIN; P=0.0006), rs964184 (C→G) of the ZPR1 zinc finger gene (ZPR1; P=0.0078) and rs599839 (G→A) of the proline/serine-rich coiled-coil 1 gene (P=0.0486) were significantly (P<0.05) associated with the prevalence of MetS. Multivariable logistic regression analysis with adjustment for age, gender and smoking status revealed that rs17514846 of FURIN (P=0.0016; odds ratio, 0.76; dominant model) and rs964184 of ZPR1 (P=0.0164; odds ratio, 1.21; dominant model) were significantly associated with MetS. The minor A allele of rs17514846 of FURIN was significantly associated with a decrease in the serum concentration of triglycerides (P=0.0293) and to an increase in the serum concentration of high-density lipoprotein (HDL) cholesterol (P=0.0460). The minor G allele of rs964184 of ZPR1 was significantly associated with increases in the serum concentration of triglycerides (P=6.2×10-9) and fasting plasma glucose level (P=0.0028) and to a decrease in the serum concentration of HDL cholesterol (P=0.0105). FURIN and ZPR1 may thus be susceptibility loci for MetS.

Entities:  

Keywords:  diabetes mellitus; dyslipidemia; genetics; metabolic syndrome; polymorphism

Year:  2015        PMID: 26405538      PMCID: PMC4534873          DOI: 10.3892/br.2015.484

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  53 in total

1.  Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.

Authors:  Yoshiji Yamada; Tamotsu Nishida; Sahoko Ichihara; Motoji Sawabe; Noriyuki Fuku; Yutaka Nishigaki; Yukitoshi Aoyagi; Masashi Tanaka; Yoshinori Fujiwara; Hiroto Yoshida; Shoji Shinkai; Kei Satoh; Kimihiko Kato; Tetsuo Fujimaki; Kiyoshi Yokoi; Mitsutoshi Oguri; Tetsuro Yoshida; Sachiro Watanabe; Yoshinori Nozawa; Aki Hasegawa; Toshio Kojima; Bok-Ghee Han; Younjin Ahn; Meehee Lee; Dong-Jik Shin; Jong Ho Lee; Yangsoo Jang
Journal:  Atherosclerosis       Date:  2010-12-15       Impact factor: 5.162

2.  Deficiency of the zinc finger protein ZPR1 causes defects in transcription and cell cycle progression.

Authors:  Laxman Gangwani
Journal:  J Biol Chem       Date:  2006-10-26       Impact factor: 5.157

3.  Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor.

Authors:  Z Galcheva-Gargova; K N Konstantinov; I H Wu; F G Klier; T Barrett; R J Davis
Journal:  Science       Date:  1996-06-21       Impact factor: 47.728

4.  Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia.

Authors:  R M Bernstein; B M Davis; J M Olefsky; G M Reaven
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

5.  Elevated furin expression in aggressive human head and neck tumors and tumor cell lines.

Authors:  D E Bassi; H Mahloogi; L Al-Saleem; R Lopez De Cicco; J A Ridge; A J Klein-Szanto
Journal:  Mol Carcinog       Date:  2001-08       Impact factor: 4.784

Review 6.  Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?

Authors:  Heidelinde Jakel; Maxime Nowak; Audrey Helleboid-Chapman; Jamila Fruchart-Najib; Jean-Charles Fruchart
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

7.  -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.

Authors:  Mirelle O Sóter; Karina B Gomes; Ana P Fernandes; Maria das G Carvalho; Poliana S Pinheiro; Adriana A Bosco; Daniel D R Silva; Marinez O Sousa
Journal:  Mol Biol Rep       Date:  2012-02-19       Impact factor: 2.316

8.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

Authors:  Sekar Kathiresan; Olle Melander; Candace Guiducci; Aarti Surti; Noël P Burtt; Mark J Rieder; Gregory M Cooper; Charlotta Roos; Benjamin F Voight; Aki S Havulinna; Björn Wahlstrand; Thomas Hedner; Dolores Corella; E Shyong Tai; Jose M Ordovas; Göran Berglund; Erkki Vartiainen; Pekka Jousilahti; Bo Hedblad; Marja-Riitta Taskinen; Christopher Newton-Cheh; Veikko Salomaa; Leena Peltonen; Leif Groop; David M Altshuler; Marju Orho-Melander
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

9.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.

Authors:  Heribert Schunkert; Inke R König; Sekar Kathiresan; Muredach P Reilly; Themistocles L Assimes; Hilma Holm; Michael Preuss; Alexandre F R Stewart; Maja Barbalic; Christian Gieger; Devin Absher; Zouhair Aherrahrou; Hooman Allayee; David Altshuler; Sonia S Anand; Karl Andersen; Jeffrey L Anderson; Diego Ardissino; Stephen G Ball; Anthony J Balmforth; Timothy A Barnes; Diane M Becker; Lewis C Becker; Klaus Berger; Joshua C Bis; S Matthijs Boekholdt; Eric Boerwinkle; Peter S Braund; Morris J Brown; Mary Susan Burnett; Ian Buysschaert; John F Carlquist; Li Chen; Sven Cichon; Veryan Codd; Robert W Davies; George Dedoussis; Abbas Dehghan; Serkalem Demissie; Joseph M Devaney; Patrick Diemert; Ron Do; Angela Doering; Sandra Eifert; Nour Eddine El Mokhtari; Stephen G Ellis; Roberto Elosua; James C Engert; Stephen E Epstein; Ulf de Faire; Marcus Fischer; Aaron R Folsom; Jennifer Freyer; Bruna Gigante; Domenico Girelli; Solveig Gretarsdottir; Vilmundur Gudnason; Jeffrey R Gulcher; Eran Halperin; Naomi Hammond; Stanley L Hazen; Albert Hofman; Benjamin D Horne; Thomas Illig; Carlos Iribarren; Gregory T Jones; J Wouter Jukema; Michael A Kaiser; Lee M Kaplan; John J P Kastelein; Kay-Tee Khaw; Joshua W Knowles; Genovefa Kolovou; Augustine Kong; Reijo Laaksonen; Diether Lambrechts; Karin Leander; Guillaume Lettre; Mingyao Li; Wolfgang Lieb; Christina Loley; Andrew J Lotery; Pier M Mannucci; Seraya Maouche; Nicola Martinelli; Pascal P McKeown; Christa Meisinger; Thomas Meitinger; Olle Melander; Pier Angelica Merlini; Vincent Mooser; Thomas Morgan; Thomas W Mühleisen; Joseph B Muhlestein; Thomas Münzel; Kiran Musunuru; Janja Nahrstaedt; Christopher P Nelson; Markus M Nöthen; Oliviero Olivieri; Riyaz S Patel; Chris C Patterson; Annette Peters; Flora Peyvandi; Liming Qu; Arshed A Quyyumi; Daniel J Rader; Loukianos S Rallidis; Catherine Rice; Frits R Rosendaal; Diana Rubin; Veikko Salomaa; M Lourdes Sampietro; Manj S Sandhu; Eric Schadt; Arne Schäfer; Arne Schillert; Stefan Schreiber; Jürgen Schrezenmeir; Stephen M Schwartz; David S Siscovick; Mohan Sivananthan; Suthesh Sivapalaratnam; Albert Smith; Tamara B Smith; Jaapjan D Snoep; Nicole Soranzo; John A Spertus; Klaus Stark; Kathy Stirrups; Monika Stoll; W H Wilson Tang; Stephanie Tennstedt; Gudmundur Thorgeirsson; Gudmar Thorleifsson; Maciej Tomaszewski; Andre G Uitterlinden; Andre M van Rij; Benjamin F Voight; Nick J Wareham; George A Wells; H-Erich Wichmann; Philipp S Wild; Christina Willenborg; Jaqueline C M Witteman; Benjamin J Wright; Shu Ye; Tanja Zeller; Andreas Ziegler; Francois Cambien; Alison H Goodall; L Adrienne Cupples; Thomas Quertermous; Winfried März; Christian Hengstenberg; Stefan Blankenberg; Willem H Ouwehand; Alistair S Hall; Panos Deloukas; John R Thompson; Kari Stefansson; Robert Roberts; Unnur Thorsteinsdottir; Christopher J O'Donnell; Ruth McPherson; Jeanette Erdmann; Nilesh J Samani
Journal:  Nat Genet       Date:  2011-03-06       Impact factor: 38.330

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

View more
  12 in total

1.  ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.

Authors:  Lakshini Weerasekera; Caroline Rudnicka; Qing-Xiang Sang; Joanne E Curran; Matthew P Johnson; Eric K Moses; Harald H H Göring; John Blangero; Jana Hricova; Markus Schlaich; Vance B Matthews
Journal:  Mediators Inflamm       Date:  2017-02-07       Impact factor: 4.711

2.  The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples.

Authors:  Sophia Harlid; Robin Myte; Bethany Van Guelpen
Journal:  Mediators Inflamm       Date:  2017-03-22       Impact factor: 4.711

3.  Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality.

Authors:  C Fernandez; J Rysä; P Almgren; J Nilsson; G Engström; M Orho-Melander; H Ruskoaho; O Melander
Journal:  J Intern Med       Date:  2018-07-02       Impact factor: 8.989

4.  Functional polymorphisms of the APOA1/C3/A4/A5-ZPR1-BUD13 gene cluster are associated with dyslipidemia in a sex-specific pattern.

Authors:  Wei Bai; Changgui Kou; Lili Zhang; Yueyue You; Weiying Yu; Wanqing Hua; Yuanyuan Li; Yaqin Yu; Tiancheng Zhao; Yanhua Wu
Journal:  PeerJ       Date:  2019-01-04       Impact factor: 2.984

Review 5.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

6.  Genome-Wide Identification of Rare and Common Variants Driving Triglyceride Levels in a Nevada Population.

Authors:  Robert W Read; Karen A Schlauch; Vincent C Lombardi; Elizabeth T Cirulli; Nicole L Washington; James T Lu; Joseph J Grzymski
Journal:  Front Genet       Date:  2021-03-02       Impact factor: 4.772

Review 7.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

8.  Identification of three genetic variants as novel susceptibility loci for body mass index in a Japanese population.

Authors:  Yoshiki Yasukochi; Jun Sakuma; Ichiro Takeuchi; Kimihiko Kato; Mitsutoshi Oguri; Tetsuo Fujimaki; Hideki Horibe; Yoshiji Yamada
Journal:  Physiol Genomics       Date:  2018-01-12       Impact factor: 3.107

9.  Impact of gender and age on the association of the BUD13-ZNF259 rs964184 polymorphism with coronary heart disease.

Authors:  Xiaofeng Xu; Yirun Li; Yi Huang; Huadan Ye; Liyuan Han; Huihui Ji; Xiaoyin Chen; Nan Wu; Danjie Jiang; Limin Xu; Dongjun Dai; Shiwei Duan; Xiaomin Chen
Journal:  Anatol J Cardiol       Date:  2018-01       Impact factor: 1.596

10.  Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.

Authors:  Georgia Ragia; Vangelis G Manolopoulos
Journal:  Pharmacogenomics       Date:  2020-11-27       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.